head and neck tumor
Showing 1 - 25 of >10,000
Squamous Cell Carcinoma of Head and Neck Trial in Toronto (fMRI, Oral Pimonidazole)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- fMRI
- Oral Pimonidazole
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Center
Oct 9, 2023
Head Neck Cancer Trial in Stockholm (DNA exome sequencing of tumor and blood)
Recruiting
- Head and Neck Cancer
- DNA exome sequencing of tumor and blood
-
Stockholm, SwedenKarolinska universitetssjukhuset
Oct 17, 2023
Imaging of Bony Structures of the Head (Various Conditions), Hearing Loss, Cholesteatoma Trial in Amsterdam (CT scan, MRI scan,
Enrolling by invitation
- Imaging of Bony Structures of the Head (Various Conditions)
- +4 more
- CT scan
- +2 more
-
Amsterdam, NetherlandsAmsterdam University Medical Center
Aug 25, 2023
Head and Neck Tumors Trial (intraoperative navigation and creation of tumor resection maps)
Not yet recruiting
- Head and Neck Tumors
- intraoperative navigation and creation of tumor resection maps
- (no location specified)
Jan 2, 2023
Head and Neck Tumors Trial in Ghent (GRID radiotherapy)
Terminated
- Head and Neck Tumors
- GRID radiotherapy
-
Ghent, BelgiumUniversity Hospital Ghent
Dec 15, 2022
Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)
Recruiting
- Unknown Primary Tumors
- Oropharynx Cancer
- Detection of lesions using fluorescence molecular imaging
-
Groningen, NetherlandsUniversity Medical Center Groningen
Oct 20, 2023
HLA-DR in Cell Cultures Isolated From Primary Squamous Cell
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cancer
- cell culture
-
Roma, Lazio, ItalyFondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Streptococcus salivarius K12, Streptococcus salivarius K12 simulants)
Completed
- Head and Neck Squamous Cell Carcinoma
- Streptococcus salivarius K12
- Streptococcus salivarius K12 simulants
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Jun 14, 2023
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Groningen (Fluorescence guided detection of tumor positive
Not yet recruiting
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
- Fluorescence guided detection of tumor positive margins
- Cetuximab-IRDye800
-
Groningen, NetherlandsUniversity Medical Center Groningen
Aug 10, 2022
Squamous Cell Carcinoma of the Oropharynx Trial in United States (Radiation Therapy)
Not yet recruiting
- Squamous Cell Carcinoma of the Oropharynx
- Radiation Therapy
-
Miami, Florida
- +3 more
Jul 22, 2023
Head and Neck Squamous Cell Cancer
Recruiting
- Head and Neck Squamous Cell Carcinoma
- OncoPrism-HNSCCâ„¢
-
San Francisco, CaliforniaCurebase
Sep 7, 2022
Tumors of Head, Neck, Thorax, Abdomen, Pelvis and Extremities.
Active, not recruiting
- Radiation Therapy Complication
- +2 more
- Spatially Fractionated Radiation (GRID) Therapy
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 31, 2022
Cancer, Severe Major Depression, Schizophrenia Trial (Virtual Cancer and Mental Health Tumor Board)
Not yet recruiting
- Cancer
- +8 more
- Virtual Cancer and Mental Health Tumor Board
- (no location specified)
Apr 26, 2023
HPV-Negative Squamous Cell Carcinoma Trial in Chicago (Paclitaxel, Carboplatin, Cetuximab)
Not yet recruiting
- HPV-Negative Squamous Cell Carcinoma
- Paclitaxel
- +6 more
-
Chicago, IllinoisUniversity of Chicago Medicine Comprehensive Cancer Center
Aug 16, 2023
Head and Neck Squamous Cell Carcinoma, Brain Metastases Trial in Nashville (Magnetic Resonance Imaging (MRI), Positron Emission
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Brain Metastases
- Magnetic Resonance Imaging (MRI)
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 10, 2023
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Head and Neck Tumors Trial (Pembrolizumab, Carboplatin, Paclitaxel)
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Pembrolizumab
- +2 more
- (no location specified)
Jun 13, 2022
Head Neck Cancer Trial in Nashville (biologic sample preservation procedure, medical chart review)
Recruiting
- Head and Neck Cancer
- biologic sample preservation procedure
- medical chart review
-
Nashville, Tennessee
- +3 more
Oct 28, 2022
Pleomorphic Adenoma of the Parotid, Warthin Tumor, Head and Neck Disorder Trial in Palo Alto (Fluorescein Sodium)
Not yet recruiting
- Pleomorphic Adenoma of the Parotid
- +2 more
- Fluorescein Sodium
-
Palo Alto, CaliforniaStanford Medical Center
Sep 19, 2023
Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Carcinoma of Vagina Trial in Shanghai (HRYZ-T101 Injection, Fludarabine
Not yet recruiting
- Cervical Cancer
- +5 more
- HRYZ-T101 Injection
- Fludarabine + Cyclophosphamide
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 17, 2023
Circulating Tumor DNA in Locally Advanced Head and Neck Squamous
Suspended
- Head and Neck Neoplasm
- Carcinoma, Squamous Cell
- Blood and tumor samples
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Feb 24, 2022
HPV-Related Squamous Cell Carcinoma, HNSCC Trial in London (VB10.16, Pembrolizumab)
Not yet recruiting
- HPV-Related Squamous Cell Carcinoma
- HNSCC
- VB10.16
- Pembrolizumab
-
London, United KingdomEast and North Hertfordshire NHS Trust Mount Vernon Hospital
Aug 24, 2023
Tumor Metabolism Indicate Radioresistance in Head and Neck
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Radiochemotherapy
-
Lucerne, SwitzerlandDepartment of Otorhinolaryngology - Head and Neck Surgery, Canto
Jan 19, 2022
Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Cancer Trial in Shanghai (Fludarabine + Cyclophosphamide,
Not yet recruiting
- Cervical Cancer
- +6 more
- Fludarabine + Cyclophosphamide
- HRYZ-T101 TCR-T Cell
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 27, 2023